Literature DB >> 21490159

Tolerance induction of IgG+ memory B cells by T cell-independent type II antigens.

Kei Haniuda1, Takuya Nojima, Kyosuke Ohyama, Daisuke Kitamura.   

Abstract

Memory B cells generated during a T cell-dependent immune response rapidly respond to a secondary immunization by producing abundant IgG Abs that bind cognate Ag with high affinity. It is currently unclear whether this heightened recall response by memory B cells is due to augmented IgG-BCR signaling, which has only been demonstrated in the context of naive transgenic B cells. To address this question, we examined whether memory B cells can respond in vivo to Ags that stimulate only through BCR, namely T cell-independent type II (TI-II) Ags. In this study, we show that the TI-II Ag (4-hydroxy-3-nitrophenyl) acetyl (NP)-Ficoll cannot elicit the recall response in mice first immunized with the T cell-dependent Ag NP-chicken γ-globulin. Moreover, the NP-Ficoll challenge in vivo as well as in vitro significantly inhibits a subsequent recall response to NP-chicken γ-globulin in a B cell-intrinsic manner. This NP-Ficoll-mediated tolerance is caused by the preferential elimination of IgG(+) memory B cells binding to NP with high affinity. These data indicate that BCR cross-linking with a TI-II Ag does not activate IgG(+) memory B cells, but rather tolerizes them, identifying a terminal checkpoint of memory B cell differentiation that may prevent autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490159     DOI: 10.4049/jimmunol.1100213

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.

Authors:  Fabian Pfrengle; Matthew S Macauley; Norihito Kawasaki; James C Paulson
Journal:  J Immunol       Date:  2013-07-08       Impact factor: 5.422

2.  B Cell Subsets Differentially Contribute to the T Cell-Independent Memory Pool.

Authors:  Christina A Daly; M Ariel Spurrier; Jamie E Jennings-Gee; Karen M Haas
Journal:  J Immunol       Date:  2020-09-25       Impact factor: 5.422

3.  B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.

Authors:  Egest J Pone; Zheng Lou; Tonika Lam; Milton L Greenberg; Rui Wang; Zhenming Xu; Paolo Casali
Journal:  Autoimmunity       Date:  2015-02       Impact factor: 2.815

Review 4.  Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

Authors:  Jeremy F Brooks; Janet M Davies; James W Wells; Raymond J Steptoe
Journal:  J Mol Med (Berl)       Date:  2017-11-17       Impact factor: 4.599

5.  Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.

Authors:  Qian Qin; Zhaojun Yin; Xuanjun Wu; Karen M Haas; Xuefei Huang
Journal:  Biomaterials       Date:  2016-06-02       Impact factor: 12.479

6.  Renal ischemia-reperfusion injury amplifies the humoral immune response.

Authors:  Richard Fuquay; Brandon Renner; Liudmila Kulik; James W McCullough; Claudia Amura; Derek Strassheim; Roberta Pelanda; Raul Torres; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

7.  Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.

Authors:  Melody Sauerborn; Miranda M C van Beers; Wim Jiskoot; Grzegorz M Kijanka; Louis Boon; Huub Schellekens; Vera Brinks
Journal:  J Clin Immunol       Date:  2012-09-04       Impact factor: 8.317

Review 8.  B cell TLRs and induction of immunoglobulin class-switch DNA recombination.

Authors:  Egest J Pone; Zhenming Xu; Clayton A White; Hong Zan; Paolo Casali
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

9.  Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.

Authors:  Xiao-Song He; Tyson H Holmes; Mrinmoy Sanyal; Randy A Albrecht; Adolfo García-Sastre; Cornelia L Dekker; Mark M Davis; Harry B Greenberg
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.